A carregar...
Weekly Exenatide Therapy: A Real-World Comparison of Incretin Therapies
Background: Traditional diabetes therapies have been associated with weight gain, hypoglycemia, and/or high secondary failure rates. Glucagon-like peptide-1 (GLP-1) analog use is associated with a minimal risk of hypoglycemia, a persistent average weight loss of 2 to 3 kg, and sustained efficacy eve...
Na minha lista:
| Publicado no: | J Pharm Technol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990137/ https://ncbi.nlm.nih.gov/pubmed/34860898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122513518189 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|